Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Saliva test for endometriosis: will it improve Women's lives?

NCT ID NCT07560852

Diagnosis Sponsor: ZIWIG Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 20,000 women who take a new saliva test (Endotest) to diagnose endometriosis. Researchers want to see how the test result—positive or negative—affects their quality of life, emotions, and care decisions. Participants fill out questionnaires and share medical data over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 20,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient with endometriosis for whom an Endotest is prescribed

Ages

18 to 43 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women with a prescription for Endotest * Women aged 18 to 43 * Who have dated and signed the consent form * Affiliated with the French healthcare system or covered by health insurance abroad Exclusion Criteria: * Contraindications for the use of Endotest: 1. Current pregnancy; 2. Medical history of cancer or HIV infection; 3. Active infection at the time of saliva collection; * Significant difficulty reading and understanding the language of the country in which the participant is located.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometriosis (diagnosis) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometriosis (diagnosis) Patient with A prescribed endotest

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Saint Etienne

    NOT_YET_RECRUITING

    Saint-Priest-en-Jarez, Pays de la Loire Region, 42270, France

  • Centre Hospitalier de Pau

    NOT_YET_RECRUITING

    Pau, Pyrénées Atlantiques, 64000, France

  • Clinique Tivoli Ducos

    RECRUITING

    Bordeaux, Gironde, 33000, France

  • Groupe Hospitalier Bretagne Sud - GHBS - Lorient

    NOT_YET_RECRUITING

    Lorient, Morbihan, 56100, France

  • Hôpital Jacques Monod - GH du Havre

    NOT_YET_RECRUITING

    Montivilliers, Seine-maritime, 76290, France

  • Hôpital de Mercy - CHR Metz Thionville

    NOT_YET_RECRUITING

    Peltre, Moselle, 57245, France

  • Hôpital privé Saint-Grégoire

    NOT_YET_RECRUITING

    Saint-Grégoire, Ille-et-Vilaine, 35760, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.